HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J M F G Aerts Selected Research

Thrombocytopenia (Thrombopenia)

11/2012Acid sphingomyelinase (Asm) deficiency patients in The Netherlands and Belgium: disease spectrum and natural course in attenuated patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J M F G Aerts Research Topics

Disease

16Gaucher Disease (Gaucher's Disease)
02/2015 - 01/2003
9Fabry Disease (Fabry's Disease)
09/2010 - 03/2004
3Bone Diseases (Bone Disease)
07/2011 - 09/2005
2Multiple Myeloma
11/2014 - 09/2013
2Insulin Resistance
03/2013 - 05/2008
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
03/2015
1Pre-Eclampsia (Preeclampsia)
02/2015
1Parkinsonian Disorders (Parkinsonism)
02/2015
1Lewy Body Disease (Lewy Body Dementia)
02/2015
1Parkinson Disease (Parkinson's Disease)
11/2014
1Hepatocellular Carcinoma (Hepatoma)
11/2014
1Pulmonary Hypertension
11/2014
1Lymphoma (Lymphomas)
09/2013
1Neoplasms (Cancer)
09/2013
1Paraproteinemias (Monoclonal Gammopathy)
09/2013
1B-Cell Lymphoma (Lymphoma, B Cell)
09/2013
1Lung Diseases (Lung Disease)
11/2012
1Niemann-Pick Diseases (Niemann Pick Disease)
11/2012
1Type B Niemann-Pick Disease
11/2012
1Type A Niemann-Pick Disease
11/2012
1Anemia
11/2012
1Thrombocytopenia (Thrombopenia)
11/2012
1Bone Resorption
07/2011
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
09/2010
1Hypertrophy
02/2010
1Vascular Diseases (Vascular Disease)
02/2010
1Cardiovascular Diseases (Cardiovascular Disease)
05/2009
1Atherosclerosis
05/2009
1Overweight
05/2008
1Weight Gain
05/2008
1Hypersensitivity (Allergy)
11/2007
1Mucopolysaccharidosis I (Hurler Syndrome)
11/2007
1Aspartylglucosaminuria
11/2006
1Lysosomal Storage Diseases (Lysosomal Storage Disease)
03/2005

Drug/Important Bio-Agent (IBA)

10EnzymesIBA
11/2014 - 01/2003
7Glucosylceramidase (Glucocerebrosidase)IBA
11/2014 - 01/2003
6Glucosylceramides (Glucocerebrosides)IBA
02/2015 - 09/2005
5Biomarkers (Surrogate Marker)IBA
03/2015 - 03/2005
5alpha-Galactosidase (Beano)IBA
09/2010 - 02/2006
4chitotriosidaseIBA
11/2014 - 01/2004
3CeramidesIBA
02/2015 - 01/2008
3globotriaosylceramide (globotriosylceramide)IBA
09/2010 - 02/2007
2AcidsIBA
02/2015 - 11/2012
2GlycosphingolipidsIBA
03/2013 - 02/2010
2miglustat (Zavesca)FDA Link
01/2004 - 01/2003
1GlucosidasesIBA
02/2015
1SphingolipidsIBA
09/2013
1sphingosyl beta-glucosideIBA
09/2013
1ParaproteinsIBA
09/2013
1Poly I-CIBA
09/2013
1Immunoglobulins (Immunoglobulin)IBA
09/2013
1prednylidene (Pred)IBA
03/2013
1taliglucerase alfaIBA
03/2013
1GlucocorticoidsIBA
03/2013
1Insulin (Novolin)FDA Link
03/2013
1Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
11/2012
1neodymium pyrocatechin disulfonate (NPD)IBA
11/2012
1OsteocalcinIBA
07/2011
1ProcollagenIBA
07/2011
1Collagen Type I (Type I Collagen)IBA
07/2011
1globotriaosyl lysosphingolipidIBA
09/2010
1HDL CholesterolIBA
05/2009
1Diphosphonates (Bisphosphonates)IBA
06/2008
1AdiponectinIBA
05/2008
1Thyroid HormonesIBA
11/2007
1CytokinesIBA
11/2007
1AntibodiesIBA
11/2007
1Iduronidase (alpha-L-Iduronidase)IBA
11/2007
1LipidsIBA
11/2006
1Therapeutic UsesIBA
01/2004
1Mannose (D-Mannose)IBA
01/2003
1Reducing AgentsIBA
01/2003
1imigluceraseFDA Link
01/2003
1GlycolipidsIBA
01/2003

Therapy/Procedure

7Enzyme Replacement Therapy
11/2014 - 11/2007
4Therapeutics
11/2014 - 01/2008
2Enzyme Therapy
07/2011 - 05/2008
1Islets of Langerhans Transplantation
03/2015
1Aftercare (After-Treatment)
03/2013
1Splenectomy
06/2008